))
Episode 30: Review of the FDA Bioresearch Monitoring (BIMO) Program
Manage episode 487998036 series 3649261
Content provided by KGK Science. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGK Science or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
The FDA’s Bioresearch Monitoring (BIMO) program is more than just inspections—it's a regulatory safeguard for the rights and welfare of clinical trial participants and the integrity of data used to support FDA submissions. In this episode, we break down the scope and function of the BIMO program, explore common findings during inspections, and discuss practical strategies for maintaining continuous inspection readiness.
Learn how sponsors, CROs, investigators, IRBs, and testing labs can stay ahead of the curve with proper documentation, monitoring, and mock audits. Ignoring BIMO findings isn’t just risky—it can delay or derail product approval. Listen in for expert insights and actionable tips to help you navigate the BIMO landscape with confidence.
32 episodes
Share
